ReShape Lifesciences (RSLS)
NASDAQ:RSLS
Holding RSLS?
Track your performance easily

ReShape Lifesciences (RSLS) Balance Sheet

464 Followers

ReShape Lifesciences Balance Sheet

ReShape Lifesciences's total assets for Q2 2024 were $6.39M, a decrease of -22.33% from the previous quarter. RSLS total liabilities were $3.36M for the fiscal quarter, a -9.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 10.66M$ 11.14M$ 52.53M$ 37.06M$ 39.66M
Total Liabilities
$ 4.00M$ 7.48M$ 8.20M$ 22.57M$ 15.55M
Total Equity Gross Minority
$ 6.74M$ 3.66M$ 44.33M$ 14.49M$ 212.39M
Total Capitalization
$ 6.81M$ 3.66M$ 54.83M$ 32.99M$ 46.84M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

ReShape Lifesciences Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis